EUVIMEDEUVIMED entdecken
Crossref

In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway

Arti Singh, Vishal Kumar, Urvashi Langeh, Lakshay Kapil, Simranjit Kaur, Nitasha Rana, Arka Bhattacharya, Rajveer Singh, Jasvinder Singh Bhatti, Charan Singh

Journal of Molecular Histology · 2024-08 · 55 (4) · 599-625

DOI: 10.1007/s10735-024-10217-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, online erschienen am 23.07.2024. Verfasst von Arti Singh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India. artiniper…. Hauptthemen laut MEDLINE: NF-kappa B, Signal Transduction, NF-E2-Related Factor 2, Berberine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Today, we critically need alternative therapeutic options for chemotherapy-induced cognitive impairment (CICI), often known as chemo brain. Mitochondrial dysfunction and oxidative stress are two of the primary processes that contribute to the development of chemobrain. Therefore, the purpose of this study was to investigate how CoQ10 and berberine shield neurons from chemotherapy-induced damage in in-vitro studies and memory loss in vivo studies. For the in-vitro investigation, we employed SH-SY5Y cell lines, and for the in-vivo study, we used female Swiss albino mice divided into seven different groups. Data from in-vitro studies revealed that treatment with coenzyme Q10 (CoQ10) and berberine improved chemotherapy-induced toxicity by reducing mitochondrial and total cellular ROS, as well as apoptosis-elicited markers (caspase 3 and 9). CoQ10 and berberine therapy inhibited the nuclear translocation of NF-κB and, consequently, the subsequent expressions of NLRP3 and IL-1β, implying the prevention of inflammasome formation. Furthermore, CoQ10 and berberine therapy boosted Nrf2 levels. This is a regulator for cellular resistance to oxidants. The in vivo results showed that treatment with CoQ10 (40 mg/kg) and berberine (200 mg/kg) improved the behavioral alterations induced by CAF (40/4/25 mg/kg) in both the Morris Water Maze (MWM) and Novel Object Recognition (NOR) tests. Furthermore, biochemical and molecular evidence revealed the antioxidant, mitochondrial restorative, and anti-inflammatory potential of CoQ10 (40 mg/kg) and berberine (200 mg/kg) against CAF (40/4/25 mg/kg) subjected mice. In addition, the histological analysis using H&E staining and transmission electron microscopy (for mitochondrial morphology) showed that mice treated with the cocktails had an increased number of healthy neurons with intact mitochondria and a reduced presence of autophagic vacuoles in the hippocampal region of the brain. These findings back up our theory about this novel cocktail method for CAF-induced cognitive impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BSignal TransductionNF-E2-Related Factor 2BerberineUbiquinoneAnimalsMiceFemaleHumansCell Line, TumorOxidative StressChemotherapy-Related Cognitive ImpairmentMitochondriaApoptosisNeurons

Stichwörter der Autor:innen

ChemobrainChemotherapyCognitive impairmentMitochondrial dysfunctionNeuroinflammationOxidative stress

Substanzen

NF-kappa BNF-E2-Related Factor 2BerberineUbiquinonecoenzyme Q10

Autor:innen und Institutionen

  • Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India. artiniper@gmail.com.
  • Department of Pharmaceutical Sciences, School of Health Science & Technology, UPES, Dehradun, India. artiniper@gmail.com.
  • Department of Pharmacology, ISF College of Pharmacy affiliated to I.K Gujral Punjab Technical University, Jalandhar, 142001, Punjab, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Hyderabad, 500037, Telangana, India.
  • Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, 142001, Punjab, India.
  • Department of Pharmacognosy, ISF College of Pharmacy, Moga, 142001, India.

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Singh, A., Kumar, V., Langeh, U., Kapil, L., Kaur, S., Rana, N., Bhattacharya, A., Singh, R., Bhatti, J. S., & Singh, C. (2024). In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway. Journal of Molecular Histology, 55(4), 599-625. https://doi.org/10.1007/s10735-024-10217-1

Vancouver

Singh A, Kumar V, Langeh U, Kapil L, Kaur S, Rana N, et al. In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway. Journal of Molecular Histology. 2024;55(4):599-625. doi:10.1007/s10735-024-10217-1

BibTeX
@article{Singh2024,
  author = {Singh, Arti and Kumar, Vishal and Langeh, Urvashi and Kapil, Lakshay and Kaur, Simranjit and Rana, Nitasha and Bhattacharya, Arka and Singh, Rajveer and Bhatti, Jasvinder Singh and Singh, Charan},
  title = {In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway},
  journal = {Journal of Molecular Histology},
  year = {2024},
  volume = {55},
  number = {4},
  pages = {599--625},
  doi = {10.1007/s10735-024-10217-1}
}
Kostenlos starten →